Peer Review reports
From: Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner
| Original Submission | ||
|---|---|---|
| 18 Aug 2023 | Submitted | Original manuscript |
| 7 Nov 2023 | Reviewed | Reviewer Report |
| 5 Dec 2023 | Reviewed | Reviewer Report |
| 8 Jan 2024 | Author responded | Author comments - W. Joost Lesterhuis |
| Resubmission - Version 2 | ||
| 8 Jan 2024 | Submitted | Manuscript version 2 |
| 9 Jan 2024 | Author responded | Author comments - W. Joost Lesterhuis |
| Resubmission - Version 3 | ||
| 9 Jan 2024 | Submitted | Manuscript version 3 |
| 12 Jan 2024 | Reviewed | Reviewer Report |
| 14 Jan 2024 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 23 Jan 2024 | Editorially accepted | |
| 13 Feb 2024 | Article published | 10.1186/s12885-024-11915-5 |
You can find further information about peer review here.